diprafenone

This page covers all diprafenone drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Beta-1 adrenergic receptor, Potassium voltage-gated channel subfamily H member 2, Sodium channel protein type 5 subunit alpha.

Targets

Beta-1 adrenergic receptor, Potassium voltage-gated channel subfamily H member 2, Sodium channel protein type 5 subunit alpha

Phase 2 pipeline (1)

• Butafenone · Cardiovascular
  Butafenone works by binding to the Beta-1 adrenergic receptor, which is involved in regulating heart rate and blood pressure.

Patent intelligence

• diprafenone patent landscape — aggregated cliff calendar, attackable patents, originator estates